How should an acute exacerbation of peptic ulcer disease be managed?

Management of Acute Exacerbation of Peptic Ulcer Disease

Initiate immediate intravenous proton pump inhibitor (PPI) therapy and perform urgent endoscopy within 24 hours for diagnosis and hemostatic treatment, followed by H. pylori testing and eradication therapy if positive.

Initial Assessment and Resuscitation

When a patient presents with acute PUD exacerbation, begin with:

• Hemodynamic assessment: Check vital signs immediately. If unstable (hypotension, tachycardia), initiate IV fluid resuscitation before further workup 1
• Laboratory studies: Order complete blood count, arterial blood gas, metabolic panel, and coagulation studies 1
• Risk stratification: Use Glasgow Blatchford score ≤1 to identify very low-risk patients who may not require hospitalization 2

Blood transfusion threshold: Transfuse if hemoglobin <80 g/L in patients without cardiovascular disease. Use a higher threshold in patients with underlying cardiac disease 2.

Diagnostic Workup

Imaging for Suspected Perforation

If perforation is suspected (sudden severe abdominal pain, peritoneal signs):

• First-line: CT scan of abdomen/pelvis with IV contrast 1
• Alternative: Chest/abdominal X-ray (erect or left lateral decubitus) if CT unavailable—detects free air in 30-85% of perforations 1
• Adjunct: Water-soluble contrast via nasogastric tube if imaging negative but clinical suspicion remains high 1

Endoscopy Timing

Perform endoscopy within 24 hours of presentation 2. Do not delay endoscopy in patients on anticoagulants (warfarin, DOACs)—proceed with or without reversal 2.

Pharmacologic Management

Acid Suppression

Start high-dose IV PPI immediately upon presentation, even before endoscopy 1:

• Standard PPI dose twice daily IV for 72-96 hours
• This downstages endoscopic lesions and reduces need for intervention, though it should not delay endoscopy 2
• After initial IV therapy, transition to oral PPI for 6-8 weeks to allow mucosal healing 1

Prokinetic Agents

Do not routinely use prokinetic agents (erythromycin, metoclopramide) before endoscopy 2. While they may improve gastric visualization, they do not reduce surgical intervention or mortality 1.

Endoscopic Treatment

Dual endoscopic therapy is recommended for active bleeding or high-risk stigmata:

• Epinephrine injection PLUS thermal coagulation or mechanical therapy (clips)
• This combination is superior to epinephrine alone for preventing rebleeding 3, 4, 5

Management of Rebleeding

If rebleeding occurs after initial endoscopic hemostasis:

• First-line: Repeat endoscopy 1
• Second-line: Transcatheter angioembolization in hemodynamically stable patients where resources available 1
• Surgical intervention: Consider if endoscopic therapy fails twice or patient remains hemodynamically unstable 1, 3

H. pylori Management

Test all patients with peptic ulcer for H. pylori 1. If positive, initiate eradication therapy after 72-96 hours of IV PPI:

First-Line Eradication (14 days)

Standard triple therapy if clarithromycin resistance is low 1:

• PPI standard dose twice daily
• Clarithromycin 500 mg twice daily
• Amoxicillin 1000 mg twice daily (or Metronidazole 500 mg twice daily if penicillin allergy)

Alternative for High Clarithromycin Resistance

Sequential therapy (10 days total) 1:

• Days 1-5: PPI twice daily + Amoxicillin 1000 mg twice daily
• Days 6-10: PPI twice daily + Clarithromycin 500 mg twice daily + Metronidazole 500 mg twice daily

Second-Line if First-Line Fails

Levofloxacin triple therapy (10 days) 1:

• PPI standard dose twice daily
• Levofloxacin 500 mg once daily (or 250 mg twice daily)
• Amoxicillin 1000 mg twice daily

Surgical Management

Indications for Surgery

• Hemodynamic instability despite resuscitation
• Failure of two endoscopic attempts at hemostasis
• Perforation with peritonitis (most perforations require surgery) 1
• Massive ongoing bleeding not amenable to endoscopic control

Antibiotic Coverage for Perforated Ulcer

Empiric broad-spectrum antibiotics are mandatory for perforated peptic ulcer to cover intra-abdominal contamination 1.

Critical Pitfalls to Avoid

1. Do not delay endoscopy waiting for anticoagulation reversal—proceed urgently 2
2. Do not discharge patients with high-risk endoscopic stigmata (active bleeding, visible vessel, adherent clot) even if hemodynamically stable
3. Do not use epinephrine injection alone—always combine with thermal or mechanical modality 3, 4
4. Do not forget H. pylori testing—eradication reduces recurrence from 50-60% to 0-2% 1, 6
5. Do not stop PPIs prematurely—continue for minimum 6-8 weeks for mucosal healing 1

Special Populations

Patients on Antiplatelet/Anticoagulant Therapy

• Continue aspirin if used for secondary cardiovascular prevention (benefits outweigh bleeding risk)
• Resume anticoagulation as soon as hemostasis achieved, typically within 7 days
• Mandatory PPI co-therapy for all patients on antithrombotic agents 7, 6

NSAID-Induced Ulcers

• Discontinue NSAID immediately—this alone heals 95% of ulcers and reduces recurrence from 40% to 9% 6
• If NSAID continuation necessary: switch to lower-risk agent (e.g., ibuprofen instead of ketorolac) + PPI therapy
• Eradicate H. pylori if present, even in NSAID users 6

Post-Discharge Management

• Confirm ulcer healing with repeat endoscopy at 8-12 weeks for gastric ulcers (to exclude malignancy)
• Verify H. pylori eradication with urea breath test or stool antigen 4-6 weeks after completing therapy
• Long-term PPI therapy only if: chronic NSAID use, recurrent ulcers despite H. pylori eradication, or high cardiovascular risk requiring antiplatelet therapy 1, 6

1, 2, 3, 4, 7, 6